New hope for myeloma patients with kidney damage
NCT ID NCT04240054
Summary
This study is testing whether adding a new drug called isatuximab to a standard three-drug combination is safe and more effective for people newly diagnosed with multiple myeloma who also have kidney problems. The goal is to see if this four-drug treatment helps more patients achieve a deep response before and after a stem cell transplant. The trial is for adults who are eligible for a transplant and have not had much prior treatment for their myeloma.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Froedtert Hospital & the Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.